Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
MAIA Biotechnology, Inc. issued 1,053,751 shares of common stock to certain accredited investors for $1.224 per share, aggregate $1,289,792.
- Security
- common stock
- Shares
- 1,053,751 shares
- Purchaser
- certain accredited investors
- Consideration
- $1.224 per share, aggregate $1,289,792
Exact text from the filing
MAIA Biotechnology, Inc. (the “ Company ”) entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with certain accredited investors (the “ Investors ”) for the issuance and sale in a private placement (the “ Private Placement ”) of: (i) 1,053,751 shares (the “ Investor Shares ”) of the Company’s common stock, par value $0.0001 per share (“ Common Stock ”), and (ii) warrants (the “ Investor Warrants ”) to purchase up to 1,053,751 shares of Common Stock, at a purchase price per Investor Share of $1.224, for an aggregate purchase price of approximately $1,289,792.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
MAIA Biotechnology, Inc. entered into Securities Purchase Agreement with certain accredited investors valued at aggregate purchase price of approximately $2,253,896 (effective 2025-12-16).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- certain accredited investors
- Value
- aggregate purchase price of approximately $2,253,896
- Effective
- 2025-12-16
Exact text from the filing
On December 16, 2025, MAIA Biotechnology, Inc. (the “ Company ”) entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with certain accredited investors (the “ Investors ”) for the issuance and sale in a private placement (the “ Private Placement ”) of: (i) 1,053,751 shares (the “ Investor Shares ”) of the Company’s common stock, par value $0.0001 per share (“ Common Stock ”), and (ii) warrants (the “ Investor Warrants ”) to purchase up to 1,053,751 shares of Common Stock, at a purchase price per Investor Share of $1.224, for an aggregate purchase price of approximately $1,289,792.
View on SEC.gov